Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0000950170-25-087813
Filing Date
2025-06-18
Accepted
2025-06-18 14:30:31
Documents
5
Effectiveness Date
2025-06-18

Document Format Files

Seq Description Document Type Size
1 S-1MEF apvo-2025-s1mef_-_june_o.htm S-1MEF 94732
2 EX-5.1 apvo-ex5_1.htm EX-5.1 40206
3 EX-23.1 apvo-ex23_1.htm EX-23.1 5129
4 EX-FILING FEES apvo-exfiling_fees.htm EX-FILING FEES 105005
5 GRAPHIC img57496738_0.jpg GRAPHIC 12962
  Complete submission text file 0000950170-25-087813.txt   264143
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-288134 | Film No.: 251056346
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)